Title:
癌性疾患修飾抗体
Document Type and Number:
Japanese Patent JP2009529010
Kind Code:
A
Abstract:
The present invention relates to a method for producing patient cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells.
More Like This:
Inventors:
Young, David, S., F.
Hahn, Susan, Yi.
Findlay, Helen, Pee.
Hahn, Susan, Yi.
Findlay, Helen, Pee.
Application Number:
JP2008557561A
Publication Date:
August 13, 2009
Filing Date:
March 05, 2007
Export Citation:
Assignee:
Arias Research, Inc.
International Classes:
A61K39/395; C07K16/32; A61P35/00; A61P43/00; C07K16/46; C12P21/08
Foreign References:
WO2004065422A2 | 2004-08-05 |
Attorney, Agent or Firm:
Kazunori Saito
Tetsuya Ito
Tetsuya Ito
Previous Patent: 乳癌及び前立腺癌における診断的及び治療的使用のための癌性疾患修飾抗...
Next Patent: 神経系疾患の予防又は治療のためのラサギリンの経皮吸収貼付剤、及びそ...
Next Patent: 神経系疾患の予防又は治療のためのラサギリンの経皮吸収貼付剤、及びそ...